Logo Logo
Hilfe
Hilfe
Switch Language to English

Argyriou, A.; Rantner, B.; Stana, J.; Tsilimparis, N.; Sensebat, O.; Torsello, G. und Stavroulakis, K. (2022): Moderne endovaskuläre Therapieoptionen bei diabetischem Fußsyndrom. In: Diabetologie, Bd. 18, Nr. 4: S. 396-401

Volltext auf 'Open Access LMU' nicht verfügbar.

Abstract

As populations in western countries continue to age, the prevalence of peripheral arterial disease (PAD) and especially chronic limb-threatening ischemia (CLTI) also increases. CLTI is the most advanced stage of limb ischemia and is associated with high mortality, increased risk of amputation, and impaired quality of life. Patients with diabetes and CLTI represent a challenging subgroup. Diabetic ulcerations and wound infections significantly increase the risk of amputation. In addition, the presence of micro-/macroangiopathy, of heavily calcified vascular disease and isolated tibial/pedal occlusions often require complex surgical and endovascular procedures. Given the increased periprocedural morbidity among patients with diabetes following bypass grafting, the introduction of novel endovascular techniques has led to a paradigm shift in the treatment of these high-risk patients. Thus, endovascular treatment is currently considered the primary treatment strategy for patients with diabetes and PAD. Aim of this article is to present the advances of endovascular therapy for patients with diabetic foot syndrome.

Dokument bearbeiten Dokument bearbeiten